Genzyme appoint new director

Accounting manager Jonathan Dennis has been appointed to the board of directors at Genzyme Therapeutics. Mr Dennis assumed his role at the biotechnology firm on July 2nd. Founded in Boston in 1981, the organisation claims to have grown from a small start-up to a diversified enterprise with annual revenues exceeding $3 billion, employing 10,000 staff worldwide.